CYCLACEL LTD has a total of 593 patent applications. It increased the IP activity by 25.0%. Its first patent ever was published in 1995. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AQUILUS PHARMACEUTICALS INC, PHARMACIA & UPJOHN and REVOTAR BIOPHARMACEUTICALS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 145 | |
#2 | EPO (European Patent Office) | 89 | |
#3 | United States | 81 | |
#4 | WIPO (World Intellectual Property Organization) | 74 | |
#5 | Australia | 40 | |
#6 | China | 36 | |
#7 | Canada | 33 | |
#8 | Brazil | 23 | |
#9 | Israel | 19 | |
#10 | Mexico | 17 | |
#11 | New Zealand | 9 | |
#12 | Hungary | 6 | |
#13 | Japan | 6 | |
#14 | Hong Kong | 5 | |
#15 | Czechia | 4 | |
#16 | Republic of Korea | 3 | |
#17 | Singapore | 2 | |
#18 | Germany | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Wang Shudong | 107 |
#2 | Fischer Peter | 63 |
#3 | Fischer Peter Martin | 59 |
#4 | Wood Gavin | 55 |
#5 | Meades Christopher | 49 |
#6 | Duncan Kenneth | 39 |
#7 | Green Simon | 37 |
#8 | Gibson Darren | 37 |
#9 | Mcinnes Campbell | 33 |
#10 | Giannella-Borradori Athos | 32 |
Publication | Filing date | Title |
---|---|---|
WO2021079129A1 | Dosing regimen | |
WO2021032958A1 | Process for the preparation of a pyrimidino-diazepine derivative | |
WO2021032959A1 | Crystalline forms of pyrimidino diazepine derivative | |
GB202000901D0 | Process | |
GB201911797D0 | Crystalline forms | |
GB201911796D0 | Process | |
US2020129509A1 | Dosing regimen | |
WO2019081951A1 | Dosing regimen | |
WO2018138500A1 | Process for preparing purine derivatives | |
GB201718106D0 | Dosing regimen | |
GB201718000D0 | Dosing regimen | |
GB201717694D0 | Dosing regimen | |
GB201701398D0 | Process | |
GB201701397D0 | Process | |
GB201701319D0 | Process | |
GB201701318D0 | Process | |
GB201609758D0 | Dosing Regimen | |
WO2013171473A1 | Dosage regimen for sapacitabine and seliciclib | |
GB201304599D0 | Dosing regimen | |
GB201208536D0 | Dosing regimen |